SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001615774-19-008234
Filing Date
2019-05-22
Accepted
2019-05-22 13:55:59
Documents
70
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q s117860_10q.htm 10-Q 880997
2 EXHIBIT 31.1 s117860_ex31-1.htm EX-31.1 11845
3 EXHIBIT 31.2 s117860_ex31-2.htm EX-31.2 11677
4 EXHIBIT 32.1 s117860_ex32-1.htm EX-32.1 8979
5 EXHIBIT 32.2 s117860_ex32-2.htm EX-32.2 8957
  Complete submission text file 0001615774-19-008234.txt   5242689

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE nspx-20180630.xml EX-101.INS 1252641
7 XBRL SCHEMA FILE nspx-20180630.xsd EX-101.SCH 42032
8 XBRL CALCULATION FILE nspx-20180630_cal.xml EX-101.CAL 45898
9 XBRL DEFINITION FILE nspx-20180630_def.xml EX-101.DEF 203648
10 XBRL LABEL FILE nspx-20180630_lab.xml EX-101.LAB 313832
11 XBRL PRESENTATION FILE nspx-20180630_pre.xml EX-101.PRE 289777
Mailing Address 2511 N LOOP 1604 W SUITE 204 SAN ANTONIO TX 78258
Business Address 2511 N LOOP 1604 W SUITE 204 SAN ANTONIO TX 78258 (210) 479-8112
Inspyr Therapeutics, Inc. (Filer) CIK: 0001421204 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55331 | Film No.: 19845087
SIC: 2834 Pharmaceutical Preparations